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ABSTRACT 
 
Alternative splicing (AS) and alternative polyadenylation (APA) generate diverse 
transcripts in mammalian genomes during development and differentiation. Epigenetic 
marks such as trimethylation of histone H3 lysine 36 (H3K36me3) and DNA 
methylation play a role in generating transcriptome diversity. Intragenic CpG islands 
(iCGIs) and their corresponding host genes exhibit dynamic epigenetic and gene 
expression patterns during development and between different tissues. We 
hypothesise that iCGI-associated H3K36me3, DNA methylation and transcription can 
influence host gene AS and/or APA. We investigate H3K36me3 and find that this 
histone mark is not a major regulator of AS or APA in our model system. Genomewide, 
we identify over 4000 host genes that harbour an iCGI in the mammalian genome, 
including both previously annotated and novel iCGI/host gene pairs. The 
transcriptional activity of these iCGIs is tissue- and developmental stage-specific and, 
for the first time, we demonstrate that the premature termination of host gene 
transcripts upstream of iCGIs is closely correlated with the level of iCGI transcription 
in a DNA-methylation independent manner. These studies suggest that iCGI 
transcription, rather than H3K36me3 or DNA methylation, interfere with host gene 
transcription and pre-mRNA processing genomewide and contributes to the 
spatiotemporal diversification of both the transcriptome and proteome. 
 
INTRODUCTION 
 
Between 20-25,000 protein coding genes have been identified in the human and 
mouse genomes that give rise to ~200,000 transcripts in tissue- and developmental 
stage-specific combinations (1). These transcripts can be generated via the use of 
alternative promoters (2) as well as co-transcriptional pre-mRNA processing 
mechanisms that include alternative splicing (AS) and alternative polyadenylation 
(APA) (3–5). Estimates based on transcriptome analyses reveal that ~90% of human 
transcripts undergo AS (6) and that APA occurs in at least 70% of mammalian pre-
mRNAs (7, 8). AS involves the differential inclusion of exons and sometimes introns 
in the mature mRNA. APA refers to the polyadenylation of transcripts originating from 
the same gene but that differ in their 3’ end (5). Both AS and APA are dependent on 
specific sequences recognised by the cellular machinery (9, 10). APA events can 
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occur either at 3’ untranslated regions (UTRs) or intragenic locations. The incidence 
of both 3’UTR-APA and intragenic polyadenylation (IPA) varies across tissues and cell 
types providing a way to diversify both the transcriptome and the proteome (11). 
Epigenetic modifications of histone tail residues and cytosine bases can 
influence AS (12–20) and APA (21–23) in developing tissues. Imprinted genes are 
particularly useful models for the dissection of epigenetic gene expression regulation 
(22, 23). There are around 130 genes in mouse and 90 genes in human that are 
subjected to genomic imprinting and are crucial for normal development (24). 
Monoallelic expression of these genes is coordinated by allele-specific DNA 
methylation of imprinting control regions (ICRs). Most ICRs acquire differential DNA 
methylation in the germline (25). Maternally methylated ICRs overlap with promoters, 
whereas paternal ICRs are found in intergenic regions (25). The active and silent 
alleles of imprinted genes share the same DNA sequence and are present within the 
same cellular environment, implying that allelic differences in gene expression are the 
consequence of epigenetic differences between the alleles (25).   
Mcts2 is an imprinted, monoexonic gene that has resulted from the 
retrotransposition of Mcts1 into the fourth intron of the H13 gene, an event that 
occurred over 90 million years ago (26). H13, referred to as the host gene, is also 
imprinted. The ICR of Mcts2/H13 is an intragenic CpG island (iCGI) that overlaps with 
the promoter of Mcts2 and undergoes DNA methylation in the female germline (22, 
27). As a consequence, Mcts2 is silent on the maternal allele that generates three H13 
transcripts (H13a, H13b, H13c), which undergo 3’UTR-APA downstream of the iCGI 
using the canonical polyadenylation sites of the H13 gene to generate full length 
transcripts. In contrast, on the paternal allele, the iCGI is unmethylated and 
transcriptionally active (22, 27). This results in two paternal H13 transcripts (H13d, 
H13e) that undergo intron retention and IPA upstream of the iCGI (Figure 1). The 
Mcts2/H13 locus therefore provides a paradigmatic example of how DNA methylation 
at iCGIs can influence AS and APA.  
It has been shown that H3K36me3 coordinates tissue-specific usage of 
alternative exons (14, 19) and prevents intron retention, possibly by facilitating the 
recognition of weak splice donor sites to ensure introns are correctly spliced out (16, 
28, 29). Importantly, H3K36me3 is deposited along the body of actively transcribing 
genes (30) where it mediates the recruitment of the de novo DNA methylation 
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machinery (31) to inhibit spurious transcription initiation from intragenic promoters 
such as iCGIs (32).  
CGIs are regulatory regions typically found at promoters but also at intragenic 
and intergenic locations. Promoter CGIs (5’CGIs) are generally unmethylated (33) but 
when methylated, this is usually associated with repression of transcription (34). 
Biochemical approaches have identified numerous CGIs within host genes (35, 36). 
iCGIs, which are highly conserved between mouse and human, show tissue-specific 
patterns of DNA methylation and transcriptional initiation during development, possibly 
indicating involvement in the spatiotemporal regulation of host gene expression, AS 
and/or IPA (35–37). The DNA methylation status of these iCGIs is dependent upon 
their host gene transcriptional activity (33). Host gene transcription across iCGIs is 
required for the recruitment of de novo DNA methylation enzymes and the silencing of 
said iCGIs. However, the intrinsic capacity of iCGIs to initiate transcription negatively 
correlates with their sensitivity to this transcription-mediated DNA methylation 
mechanism (33). The hypermethylated state of iCGIs is associated with low levels of 
preinitiation RNA Pol II occupancy, H3K36me3 enrichment and lack of H3K4me3 (33). 
Conversely, iCGIs that retain an unmethylated state show increased preinitiation RNA 
Pol II binding, are enriched in H3K4me3 and lack H3K36me3 (33). Importantly, when 
two promoters are located in relatively close proximity, similarly to iCGI/host gene 
promoters, a transcriptional process initiating from the stronger promoter can have 
suppressive influence over a second transcriptional process initiating from the weaker 
promoter, in a phenomenon known as transcriptional interference (TI) (38–41). 
Here, we sought to investigate H3K36me3 and transcription as mediators in the 
generation of alternative transcripts at the Mcts2/H13 model locus and more broadly. 
We also sought to determine the influence of intragenic transcription and DNA 
methylation on host gene pre-mRNA processing. This was achieved through the 
identification of over 4000 host genes harbouring an iCGI in the mouse genome. The 
activity of these iCGIs has been found to be tissue- and developmental stage-specific 
and, for the first time, we demonstrate that the abundance of host gene transcripts 
terminating upstream of iCGIs is closely correlated with the level of iCGI transcription. 
These studies suggest that iCGI transcription, rather than H3K36me3 or DNA 
methylation, interfere with host gene transcription and pre-mRNA processing 
genomewide, this in turn provides a means to enable spatiotemporal diversification of 
both the transcriptome and proteome. 
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MATERIALS AND METHODS 
 
Cell culture 
NIH/3T3 cells were cultured at 37 oC and 5% CO2 in DMEM high glucose (Gibco, 
41965039) supplemented with 10% FBS (Gibco, 26140079) and 1X penicillin-
streptomycin (Gibco, 15070063). Cells were harvested using 1x trypsin-EDTA (Gibco, 
25300054). 
 
RNA interference 
On day one, NIH/3T3 cells were seeded at 15,625 cells/cm2 in a well of a 6-well plate. 
After 24 hours, 3.75 l Lipofectamine 3000 (Invitrogen, L3000008) was diluted in 125 
l Opti-MEM (Gibco, 31985070). Setd2-specific or Scrambled siRNAs (OriGene, 
SR423523) were diluted in 125 l Opti-MEM to a final concentration of 10 nM. Diluted 
Lipofectamine 3000 and siRNAs were mixed and incubated for 20 minutes at room 
temperature. The siRNA-lipid complex was added to the cells and incubated for 48 
hours. Transfections were carried out in triplicate and gene expression was assayed 
by RT-qPCR. 
 
Western blot 
Protein extracts were obtained by incubating 104 cells/l in loading buffer (50 mM Tris-
Cl pH 6.8, 2% (w/v) SDS, 0.1% (w/v) bromophenol blue, 10% (v/v) glycerol, 100 mM 
DTT) at 98 oC for 5 minutes. Proteins were separated on 4-12% SDS-PAGE and 
transferred onto PVDF membrane. Successful transfer of proteins was confirmed by 
Ponceau S staining. The membranes were blocked in 5%(w/v) TBS-T BSA, incubated 
with the appropriate primary and secondary antibodies (Supplementary Table S1) and 
washed with TBS-T. Horseradish peroxidase-conjugated secondary antibody was 
detected by Pierce ECL Western Blotting Substrate (Thermo Scientific, 32106) 
coupled with iBright FL1500 Imaging System (Thermo Fisher Scientific, A44241). 
 
RNA extraction and cDNA synthesis 
Total RNA was extracted from pelleted cells using RNeasy Mini Kit (Qiagen, 74104). 
Membrane-bound genomic DNA was digested with RNase-Free DNase Set (Qiagen, 
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79254). First strand cDNA was synthesised using a ProtoScript II First Strand cDNA 
Synthesis Kit (New England Biolabs, E6560) using oligo d(T)23 primers and 500 ng 
total RNA. 
 
RT-qPCR 
RT-qPCR was performed on a QuantStudio 6 Flex Real-Time PCR System (Applied 
Biosystems) in a 10 l reaction including 1 l cDNA, 1X TaqMan Gene Expression 
Master Mix (Applied Biosystems, 4369016) and appropriate TaqMan probes 
(Supplementary Table S2). 
 
Statistical analysis. For every condition, three biological and two technical +RT 
replicates plus one technical -RT replicate were assayed. Relative gene expression 
was measured using the 2-Ct method (42). Statistical significance was determined by 
unpaired t-test assuming consistent scatter and correcting for multiple comparisons 
using the Holm-Sidak method. Alpha was defined as equal to 0.05.  
 
RNA-seq 
Library preparation and sequencing. After RNA extraction, RNA integrity was 
measured with 2200 TapeStation (Agilent) using high sensitivity RNA ScreenTape and 
reagents (Agilent, 5067-5579, 5067-5580 and 5067-5581). TruSeq Stranded mRNA 
Library Prep (Illumina, 20020594) and TruSeq RNA Single Indexes Set A (Illumina, 
20020492) were used to prepare two Scrambled and two Setd2 knockdown libraries 
from 900 ng of total RNA per library. Libraries were validated using High Sensitivity 
D1000 ScreenTape system (Agilent, 5067-5584 and 5067-5585) and KAPA Library 
Quantification Kit (Kapa Biosystems, 07960140001). All samples were sequenced on 
one Illumina HiSeq 2500 lane. 
 
Differential gene expression analysis. Raw data in the format of FastQ files were 
subject to quality control using FastQC (0.11.5) (43). Adapter sequences were 
removed using BBDuk from the BBtools kit (38.22) and the output underwent a second 
round of quality control by FastQC. mRNA-seq reads were quantified with Kallisto 
(0.44.0) (44). Differential gene expression (DGE) analysis was carried out using Sleuth 
(0.30.0) (45). Gene ontology analysis was carried out using PANTHER (14.0) (46) and 
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statistical significance was calculated with the Fisher’s exact test and the Bonferroni 
correction for multiple testing.  
 
Alternative splicing analysis. All mRNA-seq datasets were aligned to the GRCm38 
reference genome by HISAT2 (2.1.0) (47) and quality controlled using Picard 
(2.18.26). MAJIQ (1.1.7a) and Voila (1.1.9) were utilised to detect local splice variants 
(LSVs) as previously described (48). 
 
DNA extraction and bisulfite sequencing 
Genomic DNA (gDNA) was extracted form pelleted cells using DNeasy Blood and 
Tissue Kit (Qiagen, 69504). 500 ng of gDNA were bisulfite converted using EZ DNA 
Methylation-Gold Kit (Zymo Research, D5005). 
 
Amplification and cloning. Nested PCR was performed with appropriate primers 
(Supplementary Table S3) using OneTaq Hot Start DNA Polymerase (New England 
Biolabs, M0481) and OneTaq Standard Reaction Buffer (New England Biolabs, 
M0481). Amplicons were cloned into a pGEM-T Easy plasmid (Promega, A1360). 
Ligation reactions were transformed into chemically competent cells for blue-white 
colony screening. 
 
Sequencing. After colony PCR, amplicons were subject to enzymatic clean-up with 
ExoSAP-IT PCR Product Cleanup Reagent (Applied Biosystems, 78200.200.UL) and 
sequenced with T7 and SP6 primers using a BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems, 4337454) in a 3730xl DNA Analyzer (Applied 
Biosystems). 
 
Methylation analysis. Sanger sequencing results were uploaded to BISMA (49) and 
the analysis was executed using default parameters. 
 
Identification of iCGI/host gene pairs 
Strand-specific polyadenylated or non-polyadenylated RNA-seq datasets generated 
by the ENCODE project (50) were utilised. 30 different tissues and/or developmental 
stages were available for mouse (Figure 5C) and 18 cell lines for human (Figure 5D). 
Genome assemblies mm9 and hg19 were screened using the Known Genes 
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Canonical table of the UCSC genome browser in conjunction with CGI annotations 
from Illingworth et al. (36). Reads mapping upstream, across and at the iCGI were 
counted. 
 
Pearson correlation coefficients 
Pearson correlation coefficients () were calculated using the following formula: 
𝑐𝑜𝑟𝑟 (log(𝑈𝑖 + 1) − log(𝐴𝑖 + 1) ,
𝑖𝐶𝐺𝐼𝑖 − 𝑚𝑒𝑑𝑖𝑎𝑛(𝑖𝐶𝐺𝐼 + 1)
𝑚𝑎𝑑(𝑖𝐶𝐺𝐼 + 1) + 0.1
) 
This correlation coefficient measures the linear association between the transcriptional 
activity of the iCGI and the ratio of host gene expression upstream (U) and across (A) 
the iCGI calculated across available conditions (i).  values obtained with this formula 
were used to generate density plots in Figure 5B and Supplementary Figure S5. 
 
Structural analysis of CGIs 
C+G content, CpGobs/CpGexp ratios and CpG density were calculated for each CGI 
using publicly available data (36). The distribution analysis was conducted using R 
and an in-house script. 
 
Processed whole genome bisulfite sequencing data analysis 
Processed whole genome bisulfite sequencing data (bedMethyl files) were 
downloaded from ENCODE datasets. Percentage of CpG methylation at iCGIs (±5kb) 
was taken into account. The heatmap was generated using the package 
EnrichedHeatmap (51) in R and an in-house script. Accession numbers: 
GSE82669_ENCFF555SRI (lung); GSE82465_ENCFF356GTX (forebrain E13.5); 
GSE82905_ENCFF467JWP (hindbrain E13.5); GSE83043_ENCFF326GKU 
(midbrain E13.5); GSE82855_ENCFF101JDR (neural tube E13.5); 
GSE82658_ENCFF096RYX (heart); GSE82571_ENCFF051OZQ (stomach). 
 
ChIP-seq data analysis 
H3K36me3 and H3K4me3 mouse E14.5 brain ChIP-seq data from the ENCODE 
project (50) were utilised for average profiling over the host gene body and flanking 
3000 bp. Average host gene body length was calculated and divided into three 
intervals: upstream iCGI; iCGI and downstream iCGI. The logarithm of the fold 
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enrichment over input DNA was calculated at single base resolution for each locus 
and then scaled to the respective average interval length. 
 
RESULTS 
 
Global H3K36me3 depletion does not lead to increased intron retention or 
intragenic polyadenylation 
In mammals, SETD2 is a histone methyltransferase that can interact with the C-
terminal domain of phosphorylated RNA Pol II and deposit H3K36me3 along the body 
of actively transcribed genes with increasingly greater occupancy towards their 3’ ends 
(52). Previous studies have linked H3K36me3 depletion to increased intron retention 
in human kidney tumours (28, 29). Intron retention can be used as a proxy for IPA 
when measured in the context of polyadenylated mRNA since a large fraction of intron 
retention events map to the 3’ end of transcripts (53). For this reason, only 
polyadenylated mRNA was selected as a template for the synthesis of cDNA used in 
gene expression analyses. 
To investigate the involvement of H3K36me3 in intron retention and IPA in 
mouse, NIH/3T3 immortalised mouse fibroblasts were co-transfected with two Setd2-
specific siRNAs. The efficiency of the knockdown was confirmed by RT-qPCR, which 
showed an ~80% reduction in Setd2 mRNA levels in knockdown (KD) samples 
compared to wild type (WT) samples (Figure 2A). This was further validated by 
transcriptome analysis (Supplementary Figure S1). As a result, H3K36me3 was 
globally depleted (Figure 2B). KD cells showed subtle but significant changes in the 
transcription of 4266 transcripts, of which 1782 (41.77%) were downregulated and 
2484 (58.23%) were upregulated (Figure 2C). Among the downregulated transcripts, 
432 (10.13%) showed a log2(fold change) ≤-1 and 346 (8.11%) of the upregulated 
transcripts showed a log2(fold change) ≥+1 (Supplementary Figure S2A). Transcripts 
of canonical splicing and polyadenylation factors were readily detectable at similar 
levels in both WT and KD samples (Supplementary Figure S2B). Gene ontology (GO) 
analysis using all significantly upregulated genes revealed enrichment of biological 
processes associated with translation and rRNA metabolism (Figure 2D). Furthermore 
and consistent with previous findings (54, 55), modification of histones and mRNA 
metabolism were also among the upregulated biological processes (Supplementary 
Figure S2C). GO analysis using all significantly downregulated genes in KD samples 
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revealed that the most affected biological processes were DNA replication, cell cycle 
and cell migration (Figure 2E). SETD2 had previously been shown to methylate α-
tubulin (56) and to act as a key regulator of DNA mismatch repair in G1 and early S 
phase (57). Therefore, increased mitotic and cytokinetic defects were expected. To 
investigate the role of H3K36me3 in AS, splicing analysis was conducted and resulted 
in the detection of 136 significant changes in KD samples. However, only three genes 
(Ciz1, Kctd9 and Rrm2) displayed changes in intron retention and in all three cases 
this type of alternative splicing event was less frequent in the KD than in the WT 
(Supplementary Figure S3). Additionally, the percentage of intronic bases present in 
both WT and KD RNA-seq datasets was calculated and the result validated the 
splicing analysis. Examination of the mRNA-seq metrics from the final quality control 
step determined the percentage of bases mapping to intronic sequences in WT and 
KD samples to be 0.111% (± 0.00837) and 0.0994% (± 0.00705), respectively. Taken 
together, our findings suggest that H3K36me3 does not play a major role in intron 
retention of polyadenylated mRNA isoforms or IPA in NIH/3T3 cells. These results 
differ from previous studies that show increased intron retention in human kidney 
tumours characterised by SETD2 mutations (28, 29). Importantly, those observations 
are based on the analysis of RNA-seq libraries generated from total RNA rather than 
polyadenylated mRNA, which would account for unstable and/or short-lived, intron-
retaining transcripts. However, when those datasets were processed through our 
pipeline, the results were consistent with our findings (Supplementary Table S4) and 
contradicted the original studies.  
More detailed analyses were conducted to investigate a possible locus-specific 
involvement of H3K36me3 in pre-mRNA processing. Taking advantage of previous 
studies on the iCGI/host gene pair Mcts2/H13 (22, 26, 27), this locus was selected as 
a model system. Using publicly available ChIP-seq data from hybrid immortalised 
mouse fibroblasts (129/Sv x CAST/Ei) (58), H3K36me3 deposition along the 
Mcts2/H13 locus was interrogated. This histone mark is enriched on the maternal 
(129/Sv) allele at the introns that are retained in the paternally expressed (CAST/Ei) 
H13d and H13e transcripts (Figure 3). H3K36me3 has previously been shown to 
compensate for weak splice donor sites via the recruitment of specific alternative 
splicing factors (16). When H13 splice donor sites were scored (59), those present at 
exon three and four were found to be the weakest compared to the consensus 
sequence (Supplementary Table S5). It was therefore hypothesised that H3K36me3 
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may facilitate the recognition and usage of weak splice donor sites at this locus. If this 
is the case, depleting H3K36me3 would be expected to lead to decreased H13a, H13b 
and H13c isoforms and increased H13d and H13e isoforms (Figure 1). In other words, 
depletion of this histone mark would result in an increase in intron retention and IPA. 
H13a, H13b and H13c (collectively referred to as H13a-c) mRNA levels measure 
3’UTR-APA, whereas H13d and H13e expression are a proxy for intron retention and 
IPA (Figure 1). H13e was detectable only at very low levels by RT-qPCR and was not 
utilised in these expression analyses. Using the same siRNA-treated NIH/3T3 cells as 
above, RT-qPCR was employed to determine the effects of the knockdown on 
Mcts2/H13. At H13, total mRNA levels were reduced by 28% (Figure 4, H13all). H13 
isoforms terminating downstream of the iCGI also decreased by 28% (Figure 4, H13a-
c). This decrease was expected since H13a-c constitute the vast majority of H13 
transcripts (22, 27, 60). Contrary to expectations however, H13d mRNA levels 
remained unchanged (Figure 4, H13d). Expression from the iCGI was minimally 
affected (Figure 4, Mcts2) and its DNA methylation profile was not altered 
(Supplementary Figure S4). Taken together, these findings recapitulated those 
provided by the transcriptome analysis and confirmed that global H3K36me3 depletion 
via siRNA knockdown approaches may not be sufficient to lead to increased intron 
retention or IPA.  
 
iCGI activity influences host gene transcription and IPA 
The Mcts2/H13 locus provides a model for studying APA and the role of iCGIs in 
alternative transcript formation. To understand the involvement of iCGI expression in 
transcriptome diversity more broadly, we devised a strategy to estimate the number of 
loci in the genome where iCGIs reside in host gene bodies and are associated with 
tissue-specific gene expression patterns. Tissue-specific variation in transcription at 
iCGIs was determined using ENCODE RNA-seq data for 30 mouse tissues and 
developmental stages (50). 4033 host genes were identified genomewide that harbour 
iCGIs located at least 1 kb from their TSS and 500 bp from the start of their last exon. 
A negative control dataset was generated consisting of 1079 well-defined loci with 
either a corresponding protein entry in PDB or validation by RefSeq that neither 
harbour an iCGI nor overlap with other genes. Then, an artificial iCGI was simulated 
at each of the negative control loci, with its position and size randomly drawn from the 
normalised position and size distributions of the actual iCGIs. For each iCGI/host gene 
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pair identified in the genome, RNA-seq reads mapping upstream, across and at the 
iCGI were counted (Figure 5A). Additionally, the ratio of reads mapping upstream and 
across the iCGI was calculated for each gene harbouring an iCGI and used to 
determine the proportion of host gene transcripts terminating upstream of the iCGI or 
traversing the iCGI. Pearson correlation coefficients () were calculated between 
upstream:across ratios and the number of RNA-seq reads mapping to the iCGIs 
themselves. 
The distribution of  values of host genes with iCGIs was found to differ 
substantially from that of the negative control dataset (null distribution) (Figure 5B, 
upper). The null distributions are centred around zero and have a moderate range, 
indicating that this approach has a sufficient level of specificity and that extreme  
values are unlikely to occur by chance. The distributions originating from iCGI/host 
gene pairs are skewed to the right (Figure 5B), showing that increased iCGI 
transcription positively correlates with increased upstream:across ratios. In order to 
select a subset of candidate loci for further investigation, a strict cut-off value of 0.59, 
equal to the maximum  value observed in the negative data set, was imposed: 1722 
(21%) iCGI/host gene pairs scored above this threshold. The sensitivity of this 
approach was validated by the detection of the imprinted pair Nap1l5/Herc3 (=0.94) 
among the significant loci. The promoter of Nap1l5 is an iCGI that, when 
transcriptionally active, leads to Herc3 IPA (23). The same analysis was conducted 
using ENCODE RNA-seq data sets from 18 human cell lines (50) and resulted in 
similar findings (Figure 5B, lower and Supplementary Figure S5). Transcription from a 
large number of iCGIs positively correlates with upstream:across host gene 
transcription ratios. 
Using publicly available data (36), we determined C+G content, CpG observed 
over CpG expected ratio (CpGobs/CpGexp) and CpG density of the CGIs identified in 
this study. As previously shown (36), iCGIs present slightly reduced C+G content, 
CpGobs/CpGexp ratio and CpG density when compared to other CGIs (Supplementary 
Figure S6, left). In order to determine whether these features could be important in the 
apparent correlation between iCGI expression and upstream:across host gene 
transcription ratios, their distribution was interrogated in the context of iCGIs/host gene 
pairs. Thus, we observed no difference between iCGIs whose expression significantly 
correlates with upstream:across host gene transcription ratios (>0.59) and other 
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iCGIs (≤0.59) (Supplementary Figure S6, right). This indicates that these features 
have probably no involvement in the regulation of iCGIs expression and in their 
influence on host gene transcription. 
Although the model Mcts2/H13 locus is subject to genomic imprinting, we have 
shown through this analysis that the majority of the identified iCGI/host gene pairs 
(over 4000) are not imprinted, suggesting that iCGI influence on host gene 
polyadenylation is widespread and conserved across at least two mammalian species. 
 
iCGIs show DNA methylation-independent spatiotemporal transcriptional 
activity 
The transcriptional activity at iCGIs from iCGI/host gene pairs with >0.59 was 
compared across all tissues, developmental stages and cell lines. Both mouse and 
human datasets showed striking tissue-specific iCGI activity with iCGIs often being 
highly expressed in a single tissue or cell line (Figure 5C and 5D). Hierarchical 
clustering grouped mouse tissues and developmental stages from the same organ or 
system within the same cluster (Figure 5C). The hierarchical clustering was 
reproducible when using only iCGI/host gene pairs with iCGIs fully mapping within one 
intron of their host genes, excluding iCGIs partially or fully overlapping with host gene 
exons (Supplementary Figure S7A). This is important since it is not possible to 
discriminate between same-strand RNA-seq reads from host genes and iCGIs when 
the latter fully or partially overlap with host gene exons. Additionally, when intronic 
iCGIs were subjected to hierarchical clustering according to their expression level, a 
large number of iCGIs that showed high expression in brain tissues and developmental 
stages grouped together (Supplementary Figure S7A).  GO term analysis using host 
genes harbouring these iCGIs revealed enrichment of brain-specific biological 
processes (Supplementary Figure S7B and Supplementary Table S8), confirming that 
these host genes are involved in relevant cell specification processes. 
In order to establish a role for DNA methylation in the regulation of iCGIs 
transcriptional activity in mouse, ten candidate iCGI/host gene pairs that showed the 
highest correlation between iCGI transcription and upstream:across ratios were 
selected for further analysis. For each iCGI, two tissues were assayed that exhibited 
the highest and lowest measured expression levels based on RNA-seq data. For five 
of the iCGIs, the gene expression measured by RT-qPCR recapitulated the gene 
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expression patterns detected in the RNA-seq datasets (Figure 5E, left and 
Supplementary Figure S8) which is consistent with expectations. The other five iCGIs 
did not match the RNA-seq expression patterns using RT-qPCR. These RT-qPCR 
assays were perfomed in tissues that were as matched as closely as possible to the 
descriptions in the ENCODE data repository but were not the actual tissues used by 
the ENCODE consortium. Therefore, there could have been slight differences in the 
precise age of collected embryos in developmental samples or differences in the 
dissected sections of tissues, possibly accounting for discordance. In some cases, 
strain differences may also have led to discrepant findings. To confirm that Actb is a 
reliable control gene for the RT-qPCR assays, ENCODE datasets were interrogated 
for Actb expression in tissues corresponding to the ones used here (Supplementary 
Figure S9). The ENCODE data revealed that Actb expression is similar across brain, 
thymus, lung, stomach and placenta, confirming that this housekeeping gene is a 
reliable endogenous control for comparisons involving these tissues (e.g. Adck2-
Ndufb2, brain E13.5 vs stomach adult). However, lower expression levels observed in 
heart, testis and cerebellum could contribute to the discrepancy detected between the 
RNA-seq and RT-qPCR results (e.g. Bop1, brain E13.5 vs heart adult). 
The DNA methylation status of these candidate loci was assayed by PCR 
amplification of bisulfite-converted genomic DNA. At one of the concordant iCGI/host 
gene pairs, namely Hoxa, DNA methylation correlated with gene expression (Figure 
5E, right). For the other four, no correlation between iCGI expression and DNA 
methylation was detected (Figure 5E, right) suggesting that DNA methylation may not 
the major regulatory factor involved. In order to validate our observations, publicly 
available genomewide bisulfite sequencing datasets from the ENCODE project were 
utilised. Although, not all the tissues in the bisulfite sequencing PCR experiments were 
available, data from brain, lung, heart and stomach were used. When examining the 
DNA methylation percentage of the iCGIs used for validation across these tissues, it 
was found that the majority of them are unmethylated (Supplementary Figure S10). 
Variation of DNA methylation levels was observed between tissues at only one of the 
iCGIs (Dhrs3), suggesting that DNA methylation is not the only mechanism involved 
in the regulation of expression at iCGIs. 
 
Active intronic iCGIs present promoter-like chromatin  
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To determine whether these iCGIs are independent transcriptional units or a by-
product of host gene transcription, ENCODE H3K36me3 and H3K4me3 ChIP-seq 
datasets from mouse E14.5 brain (50) were interrogated. When in promoter regions, 
H3K36me3 negatively affects transcription (61), whereas H3K4me3 is considered a 
typical promoter mark and it can be found at both transcriptionally active (62) and 
poised promoters (63). In order to identify appropriate subsets for comparison, 
hierarchical clustering was applied to host gene expression upstream of the iCGI and 
the expression of the iCGI itself. This provided a means to select transcriptionally 
active host genes with very active or less active iCGIs and exclude iCGIs within 
inactive host genes from further analysis (Figure 6A). Furthermore, before plotting 
average gene body H3K36me3 and H3K4me3 profiles, only host genes with iCGIs 
fully contained within introns were selected since H3K36me3 is enriched at expressed 
exons (12). This approach revealed a sharp decrease in H3K36me3 around highly 
active iCGIs and a more subtle depletion around iCGIs expressed at low levels (Figure 
6B, upper). H3K36me3 gradually accumulates downstream of highly expressed iCGIs 
before decreasing again upstream of host gene transcription termination sites (TTSs), 
resembling the deposition of H3K36me3 along the body of actively transcribing genes 
(Figure 6B, upper left). H3K4me3 was enriched at all intronic iCGIs with a bias towards 
highly expressed iCGIs (Figure 6B, lower). Taken together, these findings suggest that 
the iCGIs tested may indeed be discrete tissue-specific promoters and that histone 
modifications could be important to regulate their expression. 
 
DISCUSSION 
 
Epigenetic modifications are associated with transcription and pre-mRNA processing. 
In some cases, the deposition of one mark is dependent upon the presence or 
absence of another. The same marks can differentially influence transcription 
depending on genomic context. For instance, DNA hypermethylation at CGI-
associated promoters negatively impacts transcription (34) but facilitates it when 
present within gene bodies (32). One post-translational histone modification has been 
extensively studied in the context of pre-mRNA processing, namely H3K36me3 (14, 
16, 28, 29, 55). This histone mark is deposited co-transcriptionally along the body of 
actively transcribing genes by the RNA Pol II-interacting histone methyltransferase 
SETD2 (52). Intriguingly, human kidney tumours with SETD2 mutations are 
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characterised by increased intron retention and altered transcription termination site 
usage (28, 29). 
We investigated the influence of H3K36me3 on intron retention and IPA in 
NIH/3T3 cells using siRNAs coupled with transcriptome analysis and locus-specific 
gene expression assays. We show that depletion of H3K36me3 leads to significant 
deregulation of 4266 transcripts and 136 AS events. Changes in intron retention are 
virtually absent between Setd2 KD and WT samples, indicating that H3K36me3 is not 
a master regulator of this type of pre-mRNA processing. Locus-specific experiments 
on the imprinted iCGI/host gene pair Mcts2/H13 are consistent with our genomewide 
conclusions since we did not detect changes in H13d transcript abundance, a proxy 
for intron retention, upon H3K36me3 depletion. These findings confirm the 
involvement of H3K36me3 in AS but differ from previous studies in human kidney 
tumours that associate SETD2 mutations with increased intron retention. This could 
be partially explained by the use of polyadenylated RNA rather than total RNA for the 
preparation of RNA-seq libraries. If H3K36me3 depletion does indeed lead to 
increased intron retention in the nucleus, there must be efficient downstream 
checkpoints that prevent the export of those transcripts into the cytoplasm. However, 
re-analysis of previous studies shows consistent percentages of bases aligning to 
intronic sequences across all datasets, suggesting that the use of improved 
bioinformatic tools could also be the basis of these discrepancies. 
Since paternal H13 transcripts are characterised by intron retention and IPA 
upstream of an actively transcribing iCGI, we interrogated the impact of transcription 
from iCGIs on host gene pre-mRNA processing more generally. We bioinformatically 
analyse 30 mouse tissues and developmental stages using RNA-seq datasets from 
the ENCODE project and identify 4033 iCGI/host gene pairs. For one in five pairs, 
iCGI activity is tissue- or developmental stage-specific and the level of host gene 
transcription upstream of the iCGI positively correlates with the level of iCGI 
transcription. We repeated the same analysis using ENCODE RNA-seq data from 18 
human cell lines and find the same results, indicating that these observations are 
reproducible across two mammalian species. Additionally, we demonstrate that this 
effect is largely independent of DNA methylation for a small subset of iCGI/host gene 
pairs. Finally, we provide evidence that these iCGIs may be discrete tissue-specific 
promoters since they are enriched for H3K4me3 and depleted of H3K36me3, a 
chromatin profile typically associated with active gene promoters (64). 
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Previous studies have shown that iCGIs become methylated and silenced when 
host gene transcription traverses them and triggers the recruitment of the de novo 
DNA methylation machinery (33). However, the methylation status of these iCGIs is 
dependent upon their intrinsic ability to initiate transcription, i.e. strong iCGIs can 
escape host gene transcription-mediated silencing (33). These iCGIs retain an 
unmethylated state, are enriched in H3K4me3 and lack H3K36me3 (33). Our work 
consolidates these findings and provides an additional layer of complexity to the cross 
talk between host gene promoters and iCGIs. We show for the first time that 
transcription from a large number of iCGIs interferes with host genes transcription in 
mouse and human, possibly providing a novel mechanism for spatiotemporal 
diversification of both transcriptome and proteome. These findings raise the question 
of precisely how iCGIs influence pre-mRNA processing of host gene transcripts. We 
speculate that iCGI activity may stimulate IPA at the expense of 3’UTR-APA in host 
genes with multiple polyadenylation sites. Isoforms resulting from IPA are typically as 
robustly expressed as full-length transcripts and therefore likely represent functional 
mRNAs rather than transcriptional noise (11). This is particularly relevant since IPA is 
important for regulating transcript diversity during differentiation and development in 
both physiological and pathological conditions (11). Using differentiation models, it will 
be important to examine the extent of the role of iCGIs in tissue- and developmental 
stage-specific gene expression and to understand the mechanisms involved. 
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LEGENDS 
 
Figure 1. Schematic representation of the Mcts2/H13 imprinted locus. Three CpG 
islands (CGIs) (green) are present at this locus: one is associated with the promoter 
of H13 (5’CGI), a second with its 3’UTR (3’CGI) and a third, intragenic one with the 
promoter of Mcts2 (iCGI). The iCGI is a germline differentially methylated region 
(gDMR) as it becomes methylated in oocytes. H13a, H13b and H13c are transcribed 
from the maternal (red) allele and undergo 3’UTR alternative polyadenylation (3’UTR-
APA). H13d, H13e and Mcts2 are transcribed from the paternal (blue) allele. H13d and 
H13e respectively retain portions of intron 4 and 3 and undergo intronic 
polyadenylation (IPA). Downward pointing arrows represent H13 alternative 
polyadenylation sites. 
 
Figure 2. (A) Setd2 mRNA levels assessed by RT-qPCR 48 hours post transfection. 
All data are normalised to Ct values for Actb. Data are given as mean 2-∆∆Ct values  
SEM of three independent experiments. ***, p<0.001 compared with Scrambled group 
by unpaired t-test. Scr, scrambled control; KD, knockdown. (B) Western blot of whole 
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cell lysate showing effective depletion of H3K36me3 upon knockdown of Setd2. Total 
histone H3 levels are unaffected. ACTB was used as a loading control. Untr, untreated 
cells; Lipo, transfection vehicle only; Scr, scrambled control; KD, knockdown. (C) 
RNA-seq heatmap of significant differentially expressed transcripts 48 hour post 
transfection. Values are given as row-wise standard-normalised fragments per 
kilobase of transcript per million mapped reads (z-score). Scr, scrambled control; KD, 
knockdown. (D) Top ten upregulated biological processes determined by GO analysis 
(PANTHER). See Supplementary Table S6 for a complete list of GO ID terms. (E) Top 
ten downregulated biological processes determined by GO analysis (PANTHER). See 
Supplementary Table S7 for a complete list of GO ID terms. 
 
Figure 3. ChIP-seq profiles for H3K4me3 and H3K36me3 from hybrid immortalised 
mouse fibroblasts mapped to the maternal (129/Sv) or paternal (CAST/Ei) allele of 
Mcts2/H13. Genomic (black) and packed maternal (red) and paternal (blue) tracks are 
shown at the top. Coverage values have been normalised by input and are indicated 
on the y-axis. Allele-specific chromatin mark enrichments are highlighted in grey. 
 
Figure 4. mRNA levels of target transcripts assessed by RT-qPCR 48 hours post 
transfection. All data are normalised to Ct values for Actb. Data are given as mean 2-
∆∆Ct values  SEM of three independent experiments. ns, p>0.05; **, p=0.01; ***, 
p<0.001 compared with Scrambled group by unpaired t-test. Scr, scrambled control; 
KD, knockdown. 
 
Figure 5. (A) Schematic representation of data collection. RNA-seq reads at iCGI/host 
gene pairs were divided into three groups according to the region they were mapped 
to: upstream, across or at the iCGI. (B) Pearson correlation coefficients () between 
transcription from the iCGI and transcription upstream:across the iCGI.  values were 
calculated in both sense (left) and antisense (right) orientations with respect to the 
host gene across 30 mouse tissues (upper) and 18 human cell lines (lower) using 
RNA-seq data from polyadenylated [poly(A)+] transcripts. A vertical blue dashed line 
is at =0. A strict cut-off is represented by a vertical green dashed line at =0.59, equal 
to the maximum  value observed in the null distribution. (C) RNA-seq heatmap 
illustrating tissue- and developmental stage-specific transcriptional activity of murine 
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iCGIs within host genes with >0.59. Values are given as column-wise standard-
normalised fragments per kilobase of transcript per million mapped reads (z-score). 
Tissues are from adult mice, unless specified. (D) RNA-seq heatmap illustrating cell 
type-specific transcriptional activity of human iCGIs within host genes with >0.59. 
Values are given as column-wise standard-normalised fragments per kilobase of 
transcript per million mapped reads (z-score). (E) Ten iCGIs from C were selected and 
labelled with the name of their host gene. Transcription from the iCGIs was measured 
by RT-qPCR in two tissues (left). All data are normalised to Ct values for Actb. Data 
are given as log10 of mean 2-∆Ct values of three independent experiments. *, 
expression is consistent with RNA-seq data in C. DNA methylation was measured by 
sequencing of bisulfite converted genomic DNA and is given as percentage values 
(right). Crossed out cells indicate that DNA methylation could not be determined. 
 
Figure 6. (A) RNA-seq heatmap from E14.5 mouse brain illustrating the transcriptional 
activity of iCGI/host gene pairs showing a >0.59 between transcription from the iCGI 
and transcription upstream:across of the iCGI (see main text and Figure 5A). Highly 
expressed iCGIs within active or inactive host genes are highlighted with green or pink 
bars, respectively. Moderately expressed iCGIs within active or inactive host genes 
are highlighted with blue or yellow bars, respectively. Values are given as column-wise 
standard-normalised fragments per kilobase of transcript per million mapped reads (z-
score). (B) Average H3K36me3 (upper) and H3K4me3 (lower) ChIP-seq profiles for 
iCGI/host gene pairs from A in which the iCGIs are fully intronic. Reads are mapped 
to the body of active host genes harbouring intronic iCGIs that are transcribed at high 
(left) or low (right) levels. TSS, transcription start site; TTS, transcription termination 
site. 
